News
News Home
Quick Bites
Exploradio
News Archive
News Channel
Special Features
NPR
nowplaying
On AirNewsClassical
Loading...
  
School Closings
WKSU Support
Funding for WKSU is made possible in part through support from the following businesses and organizations.

Meaden & Moore

Akron Children's Hospital

Knight Foundation


For more information on how your company or organization can support WKSU, download the WKSU Media Kit.

(WKSU Media Kit PDF icon )


Donate Your Vehicle to WKSU

Programs Schedule Make A Pledge Member BenefitsFAQ/HelpContact Us
Health and Medicine


Change in FDA policy fast tracks testing of Alzheimer's drug
But other scientists are unable to reproduce dramatic improvements shown in preliminary tests in Cleveland
by WKSU's JEFF ST. CLAIR


Reporter / Host
Jeff St. Clair
 
Dr. Gary Landeth (right) hopes to prove that Bexarotene can treat Alzheimer’s disease through phase 1 clinical trials. He and then graduate student Paige Cramer started a company called Rexceptor to develop the drug for clinical use.
Courtesy of Jeff St.Clair
Download (WKSU Only)
In The Region:

A promising new treatment for Alzheimer’s disease developed in Cleveland has run into some roadblocks, but backers of a repurposed drug are moving forward with clinical trials.

LISTEN: ST.CLAIR ON ALZHEIMER'S DRUG

Other options:
Windows Media / MP3 Download (1:04)


The drug Bexarotene was originally used to treat skin cancer. But Gary Landreth, a neuroscientist at Case Western Reserve University, showed last year that mice bred to have Alzheimer’s disease dramatically improved when given the drug. Now Landreth is ready to test it on people.

He says a recent change in FDA policy allows the drug to be tested on healthy people to determine whether it reduces soluble amyloid beta proteins that are believed to lead to Alzheimer’s.

“The FDA has recognized we now need to treat people who are at risk of Alzheimer’s disease but are cognitively normal, and that changes everything,” Landreth says.

The scientific community, however, is not convinced the drug actually works. Last week, the journal "Science" published independent studies that failed to reproduce Landreth’s dramatic results. However, he says he is still holding out hope his original findings in mice will be validated.

“Proving this mechanism in humans is essential to any subsequent development of the drug,” Landreth says.

Landreth says he could know by the end of the year whether Bexarotene will move on to further testing or join the dozens of other would-be Alzheimer treatments littering the path to a cure.

Listener Comments:

Does anyone have any idea as to what dosage they will be testing?


Posted by: DICKY_DOOO on May 28, 2013 4:05AM
Add Your Comment
Name:

Location:

E-mail: (not published, only used to contact you about your comment)


Comments:




 
Page Options

Print this page

E-Mail this page / Send mp3

Share on Facebook




Stories with Recent Comments

Study shows raising the cigarette tax a dollar could raise $342 million
So, it takes an expert to tell us raising the tobacco tax raises the revenue for the state? Doh. By the way, any one who was going to quit smoking probably alre...

Akron's Highland Square celebrates community spirit and public art
Both Donna and her husband, Joseph are both such amazing art talents! The photos look stunning! I must get down to Angel Falls for an in-person look. I just l...

Pluto: Another off-season, another Browns quarterback conundrum
The Browns do need a draftable QB for the future. Johnny Manziel needs to go and that leaves Brian Hoyer and Connor Shaw. Free agency doesn't really have any so...

Exploradio: Improving the lives of paralyzed people
God bless you doctor. I hope to be alive the day that humans, like me, can use the results of your search...

Nature and nourishment down by the river at the Metroparks' Merwin's Wharf
I love QUICKBITES! I look forward to it every week. One question: is it possible to include a link to the restaurant or store that you profile? Thanks!

Canton's proposed Timken-McKinley school merger is drawing spirited debate
From a sports opinion Varsity would have a lot more talent to choose from So Im sure varsity sports would improve.Also Timkens name would be much more published...

Canton school board will decide whether to merge high schools
I really hope we can save those jobs, usually we try to cut budgets but the demand is still the same. Then we look bad a year or two after the descion is made. ...

FirstEnergy wants PUCO guarantees on nuclear and coal prices
Would just comment that the plant has admitted the following (as reporting in the Akron Beacon Journal): "The utility has said it may have difficulty keeping t...

Mozzarella's easy when you have a way with curd
Hello, Where can I get such a heater that you have? Does it hold temperature that you set? What brand and model is it? Thank you in advance!! :)

Pluto: A healthy LeBron James is the key for the rocky Cavs
It's time to back our Cleveland professional teams through thick and thin. I've seen management, players and coaches come and go and it hasn't changed a thing. ...

Copyright © 2015 WKSU Public Radio, All Rights Reserved.

 
In Partnership With:

NPR PRI Kent State University

listen in windows media format listen in realplayer format Car Talk Hosts: Tom & Ray Magliozzi Fresh Air Host: Terry Gross A Service of Kent State University 89.7 WKSU | NPR.Classical.Other smart stuff. NPR Senior Correspondent: Noah Adams Living on Earth Host: Steve Curwood 89.7 WKSU | NPR.Classical.Other smart stuff. A Service of Kent State University